NASDAQ: CBRS

⬣ Investigation

technology

Cerebras Systems Inc.

Securities Investigation

Stock dropped 5.66% on October 28, 2026

Investors who purchased or acquired CBRS securities are encouraged to come forward.

Investigation in Progress — No Complaint Filed Yet

BG&G is actively investigating potential securities fraud claims against Cerebras Systems Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.

Why Is Cerebras Systems Inc. (CBRS) Under Investigation?

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Cerebras Systems Inc. (NASDAQ: CBRS).

On October 28, 2026, short seller Culper Research published a report alleging that Cerebras’s massive silicon wafers suffer from severe engineering flaws, resulting in an actual functional field lifespan of just 1.5 to 2.5 years. Culper further alleged that a proprietary connector material claimed by CEO Andrew Feldman to have been invented in-house is actually an off-the-shelf product from a third-party vendor. The report also claims that Cerebras programs its wafers to run continuous “dummy operations” to prevent them from cooling down and fracturing, forcing systems to run near peak power constantly and rapidly degrade. Culper also questioned a sudden extension in the assumed useful life of its data center equipment from 1.5–3 years to 3–5 years between early draft filings and its ultimate IPO registration statements, a modification that allegedly inflated reported first-half gross margins. Following this news, Cerebras’s stock price fell $6.75 per share, or 5.66%, to close at $112.56 per share on October 28, 2026.

What Potential Securities Violations Is BG&G Investigating?

  • Whether Cerebras Systems Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
  • Whether Cerebras Systems Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
  • Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.

What Should Cerebras Systems Inc. (CBRS) Investors Do?

If you purchased or acquired CBRS securities and suffered a loss, you may have a claim.
Contact BG&G to share relevant facts or information about your purchase.
There is no cost or obligation — our firm works exclusively on a contingency fee basis.
You do not need to have sold your shares to contact us.

How Is Cerebras Systems Inc. (NASDAQ: CBRS) Stock Trading Today?

How Does BG&G Help Investors in Securities Fraud Investigations?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner